Biotech Focus Gaia Medical Institute operates in the biotechnology research space with a pipeline centered on saliva biomarkers for point‑of‑care diagnostics, presenting potential cross‑sell opportunities for lab services, assay development, and clinical validation partnerships.

San Diego Hub Located in Southern California within San Diego’s biotech cluster, there may be synergy opportunities with nearby contract research organizations, medical device developers, and healthcare institutions seeking saliva‑based diagnostic solutions.

Moderate Revenue With annual revenue ranging from one to ten million, Gaia may be receptive to strategic partnerships, grant collaborations, and pilot programs to expand test offerings and accelerate go‑to‑market activities.

Tech Stack Utilizing cloud platforms (AWS, Google Cloud), modern web presence (Wix/WordPress), and security/CDN tools, Gaia is positioned to collaborate on scalable digital health solutions, data analytics, and compliant patient data management.

Pipeline Diversity A diversified saliva test pipeline—including traumatic brain injury, dehydration, infectious diseases, and cancer‑related indicators—suggests cross‑selling to hospitals, clinics, and sports medicine programs seeking multi‑analyte diagnostics.